LncRNA PVT1 Knockdown Ameliorates Myocardial Ischemia Reperfusion Damage via Suppressing Gasdermin D-Mediated Pyroptosis in Cardiomyocytes

Objective: Myocardial ischemia reperfusion (I/R) damage is a life-threatening vascular emergency after myocardial infarction. Here, we observed the cardioprotective effect of long non-coding RNA (lncRNA) PVT1 knockdown against myocardial I/R damage. Methods: This study constructed a myocardial I/R-induced mouse model and a hypoxia/reoxygenation (H/R)-treated H9C2 cells. PVT1 expression was examined via RT-qPCR. After silencing PVT1 via shRNA against PVT1, H&E, and Masson staining was performed to observe myocardial I/R damage. Indicators of myocardial injury including cTnI, LDH, BNP, and CK-MB were examined by ELISA. Inflammatory factors (TNF-α, IL-1β, and IL-6), Gasdermin D (GSDMD), and Caspase1 were detected via RT-qPCR, western blot, immunohistochemistry, or immunofluorescence. Furthermore, CCK-8 and flow cytometry were presented for detecting cell viability and apoptosis. Results: LncRNA PVT1 was markedly up-regulated in myocardial I/R tissue specimens as well as H/R-induced H9C2 cells. Silencing PVT1 significantly lowered serum levels of cTnI, LDH, BNP, and CK-MB in myocardial I/R mice. H&E and Masson staining showed that silencing PVT1 alleviated myocardial I/R injury. PVT1 knockdown significantly lowered the production and release of inflammatory factors as well as inhibited the expression of GSDMD-N and Caspase1 in myocardial I/R tissue specimens as well as H/R-induced H9C2 cells. Moreover, silencing PVT1 facilitated cell viability and induced apoptosis of H/R-treated H9C2 cells. Conclusion: Our findings demonstrated that silencing PVT1 could alleviate myocardial I/R damage through suppressing GSDMD-mediated pyroptosis in vivo and in vitro. Thus, PVT1 knockdown may offer an alternative therapeutic strategy against myocardial I/R damage.

[1]  Feng Chen,et al.  Nicorandil inhibits TLR4/MyD88/NF-κB/NLRP3 signaling pathway to reduce pyroptosis in rats with myocardial infarction , 2021, Experimental biology and medicine.

[2]  J. Ge,et al.  GSDMD-Mediated Cardiomyocyte Pyroptosis Promotes Myocardial I/R Injury , 2021, Circulation research.

[3]  Min Gao,et al.  lncRNA PVT1 modulates NLRP3‑mediated pyroptosis in septic acute kidney injury by targeting miR‑20a‑5p. , 2021, Molecular medicine reports.

[4]  Xiaofeng Yu,et al.  Panax quinquefolius L. Saponins Protect Myocardial Ischemia Reperfusion No-Reflow Through Inhibiting the Activation of NLRP3 Inflammasome via TLR4/MyD88/NF-κB Signaling Pathway , 2021, Frontiers in Pharmacology.

[5]  R. Geffers,et al.  Different DOACs Control Inflammation in Cardiac Ischemia-Reperfusion Differently. , 2020, Circulation research.

[6]  Sally E Abu-Risha,et al.  Octreotide and melatonin alleviate inflammasome-induced pyroptosis through inhibiting TLR4-NF-κB-NLRP3 pathway in hepatic ischemia/reperfusion injury. , 2020, Toxicology and applied pharmacology.

[7]  Bang-long Xu,et al.  Uric acid aggravates myocardial ischemia-reperfusion injury via ROS/NLRP3 pyroptosis pathway. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[8]  Xiangbin Meng,et al.  Downregulating long non-coding RNA PVT1 expression inhibited the viability, migration and phenotypic switch of PDGF-BB-treated human aortic smooth muscle cells via targeting miR-27b-3p , 2020, Human Cell.

[9]  Xianbao Wang,et al.  Cardioprotection of pharmacological postconditioning on myocardial ischemia/reperfusion injury. , 2020, Life sciences.

[10]  Liming Yu,et al.  Melatonin attenuates diabetic cardiomyopathy and reduces myocardial vulnerability to ischemia‐reperfusion injury by improving mitochondrial quality control: Role of SIRT6 , 2020, Journal of pineal research.

[11]  G. Heusch.  Myocardial ischaemia–reperfusion injury and cardioprotection in perspective , 2020, Nature Reviews Cardiology.

[12]  X. Zhao,et al.  Expression level of lncRNA PVT1 in serum of patients with coronary atherosclerosis disease and its clinical significance. , 2020, European Review for Medical and Pharmacological Sciences.

[13]  Yali Yao,et al.  lncRNA Oip5‐as1 attenuates myocardial ischaemia/reperfusion injury by sponging miR‐29a to activate the SIRT1/AMPK/PGC1α pathway , 2020, Cell proliferation.

[14]  Q. Ding,et al.  Knockdown of long non-coding RNA PVT1 protects human AC16 cardiomyocytes from hypoxia/reoxygenation-induced apoptosis and autophagy by regulating miR-186/Beclin-1 axis. , 2020, Gene.

[15]  H. Bugger,et al.  Mitochondrial ROS in myocardial ischemia reperfusion and remodeling. , 2020, Biochimica et biophysica acta. Molecular basis of disease.

[16]  P. Shi,et al.  DNMT1 Methylation of LncRNA GAS5 Leads to Cardiac Fibroblast Pyroptosis via Affecting NLRP3 Axis , 2020, Inflammation.

[17]  Qiang Wang,et al.  Long non-coding RNA MEG3 promotes cerebral ischemia-reperfusion injury through increasing pyroptosis by targeting miR-485/AIM2 axis , 2019, Experimental Neurology.

[18]  Q. Mao,et al.  LncRNA KLF3-AS1 in human mesenchymal stem cell-derived exosomes ameliorates pyroptosis of cardiomyocytes and myocardial infarction through miR-138-5p/Sirt1 axis , 2019, Stem Cell Research & Therapy.

[19]  Y. Leng,et al.  Ferroptosis Is Involved in Diabetes Myocardial Ischemia/Reperfusion Injury Through Endoplasmic Reticulum Stress. , 2019, DNA and cell biology.

[20]  Fan Deng,et al.  LncRNA MALAT1 Promotes Oxygen-Glucose Deprivation and Reoxygenation Induced Cardiomyocytes Injury Through Sponging miR-20b to Enhance beclin1-Mediated Autophagy , 2019, Cardiovascular Drugs and Therapy.

[21]  Ning Wang,et al.  Kanglexin, a novel anthraquinone compound, protects against myocardial ischemic injury in mice by suppressing NLRP3 and pyroptosis , 2019, Acta Pharmacologica Sinica.

[22]  Jinyu Huang,et al.  Long non-coding RNA FOXD3-AS1 aggravates ischemia/reperfusion injury of cardiomyocytes through promoting autophagy. , 2019, American journal of translational research.

[23]  X. Xue,et al.  RETRACTED ARTICLE: LncRNA HIF1A-AS1 contributes to ventricular remodeling after myocardial ischemia/reperfusion injury by adsorption of microRNA-204 to regulating SOCS2 expression , 2019, Cell cycle.

[24]  Erping Long,et al.  LncRNA H19 initiates microglial pyroptosis and neuronal death in retinal ischemia/reperfusion injury , 2019, Cell Death & Differentiation.

[25]  Weijian Huang,et al.  Emodin alleviates myocardial ischemia/reperfusion injury by inhibiting gasdermin D-mediated pyroptosis in cardiomyocytes , 2019, Drug design, development and therapy.

[26]  Ling Yan,et al.  LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation , 2019, Molecular Medicine.

[27]  Jianyang Liu,et al.  Knockdown of lncRNA PVT1 Inhibits Vascular Smooth Muscle Cell Apoptosis and Extracellular Matrix Disruption in a Murine Abdominal Aortic Aneurysm Model , 2019, Molecules and cells.

[28]  F. Cao,et al.  Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats. , 2018, Acta biomaterialia.

[29]  Peng Li,et al.  Alamandine attenuates sepsis‐associated cardiac dysfunction via inhibiting MAPKs signaling pathways , 2018, Life sciences.

[30]  K. Yan,et al.  LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription , 2018, Nature Communications.

[31]  L. Xiong,et al.  TNF-α antagonism ameliorates myocardial ischemia-reperfusion injury in mice by upregulating adiponectin. , 2015, American journal of physiology. Heart and circulatory physiology.

[32]  Zuo-ying Hu,et al.  Cardiac hypertrophy is positively regulated by long non-coding RNA PVT1. , 2015, International journal of clinical and experimental pathology.

[33]  E. Ashley,et al.  Chromatin regulation by Brg1 underlies heart muscle development and disease , 2010, Nature.

[34]  E. Alnemri,et al.  Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression1 , 2009, The Journal of Immunology.